Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
168.70    -2.20 (-1.29%)
Bid:
168.30
Ask:
168.70
Spread: 0.40 (0.238%)
Market Cap: £746.13m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Directorate Change

22 Dec 2020 16:25

RNS Number : 5844J
Pets At Home Group Plc
22 December 2020
 

FOR IMMEDIATE RELEASE, 22 December 2020

Pets at Home Group Plc: Directorate Change 

 

Pets at Home Group Plc, the UK's leading pet care business, announces the appointment of Zarin Patel as independent non-executive Director with effect from 14 April 2021. Zarin will succeed Karen Whitworth as Chair of the Audit and Risk Committee when Karen steps down on 20 May 2021.

Zarin is a chartered accountant who spent 16 years at KPMG followed by a nine year period as Chief Financial Officer of the BBC and latterly was the Chief Operating Officer of The Grass Roots Group plc, a customer and employee engagement specialist.

Zarin is a non-executive director and Chair of the Audit Committee of Anglian Water Services Limited, a non-executive director of Post Office Limited and an independent member of the Audit and Risk Committees of both HM Treasury and John Lewis Partnership plc, although the latter appointment will end on 13 April 2021. Zarin is a Trustee of National Trust and chair of its Audit Committee.

On appointment, Zarin will become Chair of the Audit and Risk Committee and a member of both the Remuneration Committee and the Nominations and Corporate Governance Committee.

 

Ian Burke, Chairman of Pets at Home, commented:

"On behalf of the Board, it gives me great pleasure to welcome Zarin Patel to Pets at Home Group plc. Zarin brings a wealth of experience to Pets at Home and will add value to the Board's commercial discussions as a result. I look forward to working with her next year."

 

This disclosure is given in accordance with Listing Rule 9.6.11.

 

 

Enquiries

Pets at Home Group Plc:

Lucy Williams, Company Secretary

+44 (0)161 468 6688

 

Investor Relations/Media EnquiriesPets at Home Group Plc:

Roger Tejwani, Director of Investor Relations & External Communications+44 (0)1279 927022

 

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business; our commitment is to make sure pets and their owners get the very best advice, products and care. Pet products are available online or from our 451 stores, many of which also have vet practices and grooming salons. Pets at Home also operates a UK leading small animal veterinary business, with 440 First Opinion practices located both in our stores and in standalone locations, as well as five Specialist Referral centres. For more information visit: http://investors.petsathome.com/

 

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser.

 

Certain statements in this trading statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFFRFVLFFII
Date   Source Headline
23rd Dec 20257:00 amRNSAppointment of CEO
23rd Dec 20257:00 amRNSAppointment of CEO
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSFY26 Interim Results
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares*
3rd Nov 20257:00 amRNSTotal Voting Rights
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 202510:23 amRNSChange in Director's details
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.